Hartvig Camilla Harder

Track

Insider profile

Hartvig Camilla Harder's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
198.42
Quantity 91,198
Value US$4,251,765
Transaction date
Proposed sale
Price
424.10
Quantity 44,908
Value US$2,120,567
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-04 2025-03-04
PrS Proposed sale
91,198
198.42
US$4,251,765 		91,198 198.42 US$4,251,765
2024-11-19 2024-11-19
PrS Proposed sale
44,908
424.10
US$2,120,567 		44,908 424.10 US$2,120,567